Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 evolution and immune escape in immunocompromised patients treated with exogenous antibodies

Erin M. Scherer, View ORCID ProfileAhmed Babiker, Max W. Adelman, Brent Allman, Autum Key, Jennifer M. Kleinhenz, Rose M. Langsjoen, Phuong-Vi Nguyen, Ivy Onyechi, Jacob D. Sherman, Trevor W. Simon, Hannah Soloff, Jessica Tarabay, Jay Varkey, Andrew S. Webster, Daniela Weiskopf, Daniel B. Weissman, Yongxian Xu, Jesse J. Waggoner, Katia Koelle, Nadine Rouphael, Stephanie M. Pouch, Anne Piantadosi
doi: https://doi.org/10.1101/2022.04.12.22273675
Erin M. Scherer
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
2Hope Clinic of the Emory Vaccine Center, Emory University School of Medicine, Decatur, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: erin.margaret.scherer@emory.edu anne.piantadosi@emory.edu
Ahmed Babiker
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
3Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ahmed Babiker
Max W. Adelman
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brent Allman
4Population Biology, Ecology, and Evolution Graduate Program, Laney Graduate School, Emory University, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Autum Key
3Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer M. Kleinhenz
2Hope Clinic of the Emory Vaccine Center, Emory University School of Medicine, Decatur, GA, USA
5Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rose M. Langsjoen
3Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phuong-Vi Nguyen
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivy Onyechi
6Emory Integrated Genomics Core, Emory University, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob D. Sherman
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
2Hope Clinic of the Emory Vaccine Center, Emory University School of Medicine, Decatur, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Trevor W. Simon
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
2Hope Clinic of the Emory Vaccine Center, Emory University School of Medicine, Decatur, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannah Soloff
7Emory University, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Tarabay
8Emory Healthcare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jay Varkey
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew S. Webster
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela Weiskopf
9Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel B. Weissman
10Department of Physics, Emory University, Atlanta, GA, USA
11Department of Biology, Emory University, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yongxian Xu
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
2Hope Clinic of the Emory Vaccine Center, Emory University School of Medicine, Decatur, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesse J. Waggoner
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katia Koelle
11Department of Biology, Emory University, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadine Rouphael
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
2Hope Clinic of the Emory Vaccine Center, Emory University School of Medicine, Decatur, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie M. Pouch
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Piantadosi
1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
3Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: erin.margaret.scherer@emory.edu anne.piantadosi@emory.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background SARS-CoV-2 mutations conferring escape from neutralizing antibodies can arise in immunocompromised patients with prolonged infection, but the conditions that facilitate immune escape are still not fully understood.

Methods We characterized endogenous immune responses, within-host SARS-CoV-2 evolution, and autologous neutralization of the viral variants that arose in five immunocompromised patients with prolonged infection and B cell deficiencies.

Results In two patients treated with the monoclonal antibody bamlanivimab, viral resistance to autologous serum arose early and persisted for several months, accompanied by ongoing evolution in the spike protein. These patients exhibited deficiencies in both T and B cell arms, and one patient succumbed to disease. In contrast, we did not observe spike mutations in immunologically important regions in patients who did not receive exogenous antibodies or who received convalescent plasma and had intact T cell responses to SARS-CoV-2.

Conclusions Our results underscore the potential importance of multiple factors – the absence of an effective endogenous immune response, persistent virus replication, and selective pressure such as single-agent bamlanivimab – in promoting the emergence of SARS-CoV-2 mutations associated with immune evasion. These findings highlight the need for larger clinical studies in immunocompromised populations to better understand the ramifications of different therapies. Our results also confirm that patients with B cell deficiencies can elicit effector T cells and may suggest an important role for T cells in controlling infection, which is relevant to vaccines and therapeutics.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by CDC contract 75D30121C10084 under BAA ERR 20-15-2997 (AB, JW, KK, AP), National Institutes of Health (NIH) grant 5UM1AI148576-02 (NR and EMS), the Pediatric Research Alliance Center for Childhood Infections and Vaccines and Childrens Healthcare of Atlanta, and the Emory Woodruff Health Sciences Center COVID-19 Urgent Research Engagement (CURE) Center, made possible by generous philanthropic support from the O. Wayne Rollins Foundation and the William Randolph Hearst Foundation. Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the NIH under Award Number K08AI139348 (AP) and NIH contract No. 75N9301900065 (DW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. LJI has filed for patent protection for various aspects of T cell epitope and vaccine design work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the institutional review board at Emory University under protocols STUDY00000260, 00022371, and 00045821. Clinical data was obtained by electronic medical review. Residual nasopharyngeal (NP) swab and serum samples were obtained from the Emory Medical Labs. Whole blood samples were obtained after patient enrollment and consent.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All sequence data (cleaned of human reads) are available on NCBI under BioProject PRJNA634356. SARS-CoV-2 consensus sequences are available in GISAID under accession numbers EPI_ISL_1503958 and EPI_ISL_6913932-43.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 19, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 evolution and immune escape in immunocompromised patients treated with exogenous antibodies
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 evolution and immune escape in immunocompromised patients treated with exogenous antibodies
Erin M. Scherer, Ahmed Babiker, Max W. Adelman, Brent Allman, Autum Key, Jennifer M. Kleinhenz, Rose M. Langsjoen, Phuong-Vi Nguyen, Ivy Onyechi, Jacob D. Sherman, Trevor W. Simon, Hannah Soloff, Jessica Tarabay, Jay Varkey, Andrew S. Webster, Daniela Weiskopf, Daniel B. Weissman, Yongxian Xu, Jesse J. Waggoner, Katia Koelle, Nadine Rouphael, Stephanie M. Pouch, Anne Piantadosi
medRxiv 2022.04.12.22273675; doi: https://doi.org/10.1101/2022.04.12.22273675
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 evolution and immune escape in immunocompromised patients treated with exogenous antibodies
Erin M. Scherer, Ahmed Babiker, Max W. Adelman, Brent Allman, Autum Key, Jennifer M. Kleinhenz, Rose M. Langsjoen, Phuong-Vi Nguyen, Ivy Onyechi, Jacob D. Sherman, Trevor W. Simon, Hannah Soloff, Jessica Tarabay, Jay Varkey, Andrew S. Webster, Daniela Weiskopf, Daniel B. Weissman, Yongxian Xu, Jesse J. Waggoner, Katia Koelle, Nadine Rouphael, Stephanie M. Pouch, Anne Piantadosi
medRxiv 2022.04.12.22273675; doi: https://doi.org/10.1101/2022.04.12.22273675

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Intensive Care and Critical Care Medicine
Subject Areas
All Articles
  • Addiction Medicine (229)
  • Allergy and Immunology (507)
  • Anesthesia (111)
  • Cardiovascular Medicine (1253)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (283)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (537)
  • Epidemiology (10039)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2471)
  • Geriatric Medicine (239)
  • Health Economics (482)
  • Health Informatics (1649)
  • Health Policy (756)
  • Health Systems and Quality Improvement (637)
  • Hematology (250)
  • HIV/AIDS (536)
  • Infectious Diseases (except HIV/AIDS) (11878)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (255)
  • Medical Ethics (75)
  • Nephrology (269)
  • Neurology (2298)
  • Nursing (140)
  • Nutrition (354)
  • Obstetrics and Gynecology (456)
  • Occupational and Environmental Health (537)
  • Oncology (1254)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (326)
  • Pediatrics (736)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2288)
  • Public and Global Health (4849)
  • Radiology and Imaging (844)
  • Rehabilitation Medicine and Physical Therapy (493)
  • Respiratory Medicine (653)
  • Rheumatology (287)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (227)
  • Surgery (271)
  • Toxicology (44)
  • Transplantation (128)
  • Urology (99)